Highest Price Target1
Lowest Price Target1
Consensus Price Target1
Analyst Rating Summary1
| Buy | Overweight | Hold | Underweight | Sell |
|---|---|---|---|---|
| 8 | 0 | 0 | 0 | 0 |
Analyst Firms Making Recommendations1
- Truist Securities
- Needham
- BTIG
- JMP Securities
- Stifel
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for OrthoPediatrics
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/08/2023 | KIDS | Buy Now | OrthoPediatrics | $30.73 | 13.88% | Truist Securities | Richard Newitter | $31 → $35 | Maintains | Buy | Get Alert |
| 11/07/2023 | KIDS | Buy Now | OrthoPediatrics | $30.73 | 20.38% | Needham | Mike Matson | $55 → $37 | Maintains | Buy | Get Alert |
| 10/04/2023 | KIDS | Buy Now | OrthoPediatrics | $30.73 | 69.19% | BTIG | Ryan Zimmerman | $59 → $52 | Maintains | Buy | Get Alert |
| 09/01/2023 | KIDS | Buy Now | OrthoPediatrics | $30.73 | 95.22% | JMP Securities | David Turkaly | → $60 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 08/02/2023 | KIDS | Buy Now | OrthoPediatrics | $30.73 | 65.93% | Truist Securities | Richard Newitter | $57 → $51 | Maintains | Buy | Get Alert |
| 08/01/2023 | KIDS | Buy Now | OrthoPediatrics | $30.73 | 95.22% | JMP Securities | David Turkaly | → $60 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 08/01/2023 | KIDS | Buy Now | OrthoPediatrics | $30.73 | 78.95% | Needham | Mike Matson | → $55 | Reiterates | Buy → Buy | Get Alert |
| 05/02/2023 | KIDS | Buy Now | OrthoPediatrics | $30.73 | 78.95% | Needham | Mike Matson | $51 → $55 | Maintains | Buy | Get Alert |
| 05/02/2023 | KIDS | Buy Now | OrthoPediatrics | $30.73 | 95.22% | JMP Securities | David Turkaly | → $60 | Reiterates | → Market Outperform | Get Alert |
| 04/17/2023 | KIDS | Buy Now | OrthoPediatrics | $30.73 | 65.93% | Needham | Mike Matson | → $51 | Maintains | Buy | Get Alert |
| 04/17/2023 | KIDS | Buy Now | OrthoPediatrics | $30.73 | 85.46% | Truist Securities | Richard Newitter | $53 → $57 | Maintains | Buy | Get Alert |
| 03/01/2023 | KIDS | Buy Now | OrthoPediatrics | $30.73 | 65.93% | Needham | Mike Matson | $50 → $51 | Maintains | Buy | Get Alert |
| 01/31/2023 | KIDS | Buy Now | OrthoPediatrics | $30.73 | 82.2% | Truist Securities | Richard Newitter | $47 → $56 | Maintains | Buy | Get Alert |
| 01/10/2023 | KIDS | Buy Now | OrthoPediatrics | $30.73 | 62.68% | Stifel | Rick Wise | $52 → $50 | Maintains | Buy | Get Alert |
| 11/02/2022 | KIDS | Buy Now | OrthoPediatrics | $30.73 | 95.22% | JMP Securities | David Turkaly | $70 → $60 | Maintains | Market Outperform | Get Alert |
| 11/01/2022 | KIDS | Buy Now | OrthoPediatrics | $30.73 | 62.68% | Needham | Mike Matson | $59 → $50 | Maintains | Buy | Get Alert |
What is the target price for OrthoPediatrics (KIDS)?
The latest price target for OrthoPediatrics (NASDAQ: KIDS) was reported by Truist Securities on November 8, 2023. The analyst firm set a price target for $35.00 expecting KIDS to rise to within 12 months (a possible 13.88% upside). 14 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for OrthoPediatrics (KIDS)?
The latest analyst rating for OrthoPediatrics (NASDAQ: KIDS) was provided by Truist Securities, and OrthoPediatrics maintained their buy rating.
When is the next analyst rating going to be posted or updated for OrthoPediatrics (KIDS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of OrthoPediatrics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for OrthoPediatrics was filed on November 8, 2023 so you should expect the next rating to be made available sometime around November 8, 2024.
Is the Analyst Rating OrthoPediatrics (KIDS) correct?
While ratings are subjective and will change, the latest OrthoPediatrics (KIDS) rating was a maintained with a price target of $31.00 to $35.00. The current price OrthoPediatrics (KIDS) is trading at is $30.74, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.